John C. Hunter

13.8k total citations · 1 hit paper
186 papers, 9.6k citations indexed

About

John C. Hunter is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, John C. Hunter has authored 186 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 64 papers in Cellular and Molecular Neuroscience and 52 papers in Physiology. Recurrent topics in John C. Hunter's work include Neuropeptides and Animal Physiology (42 papers), Pain Mechanisms and Treatments (39 papers) and Receptor Mechanisms and Signaling (32 papers). John C. Hunter is often cited by papers focused on Neuropeptides and Animal Physiology (42 papers), Pain Mechanisms and Treatments (39 papers) and Receptor Mechanisms and Signaling (32 papers). John C. Hunter collaborates with scholars based in United States, United Kingdom and Switzerland. John C. Hunter's co-authors include Richard M. Eglen, Frank Porreca, Josephine Lai, Kenneth D. Westover, Lakshmi Sangameswaran, Eva M. Escobedo, Sanja D. Novaković, Martin A. Carrasco, Deepak Gurbani and Joel W. Hughes and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John C. Hunter

184 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

2015 520 citations John C. Hunter, Anuj Manandhar et al. Molecular Cancer Research profile →

Peers

Countries citing papers authored by John C. Hunter

Since Specialization

Citations

This map shows the geographic impact of John C. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Hunter more than expected).

Fields of papers citing papers by John C. Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Hunter. The network helps show where John C. Hunter may publish in the future.

Co-authorship network of co-authors of John C. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Hunter. A scholar is included among the top collaborators of John C. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Hunter. John C. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ST‐2560, a selective inhibitor of the Na_V1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates 2024 ·British Journal of Pharmacology ·John V. Mulcahy, Jacob T. Beckley, (unknown), (unknown), Anton Delwig, Hassan Pajouhesh, (unknown), Xiang Zhou, J. Du Bois, David C. Yeomans, George Luu, John C. Hunter	7
2	Discovery of Selective Inhibitors of Na_V1.7 Templated on Saxitoxin as Therapeutics for Pain 2022 ·ACS Medicinal Chemistry Letters ·Hassan Pajouhesh, Anton Delwig, Jacob T. Beckley, (unknown), (unknown), Xiang Zhou, George Luu, J. Du Bois, John C. Hunter, John V. Mulcahy	7
3	Structure-guided development of covalent TAK1 inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Li Tan, Deepak Gurbani, Ellen Weisberg, John C. Hunter, Lianbo Li, D. S. Jones, Scott B. Ficarro, (unknown), Chun Pong Tam, (unknown), Guangyan Du, James D. Griffin, Peter K. Sorger, Jarrod A. Marto, Kenneth D. Westover, Nathanael S. Gray	26
4	Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations breakdown → 2015 ·Molecular Cancer Research ·John C. Hunter, Anuj Manandhar, Martin A. Carrasco, Deepak Gurbani, Sudershan Reddy Gondi, Kenneth D. Westover	520
5	Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model 2013 ·Pharmacology Biochemistry and Behavior ·(unknown), Tatiana M. Kazdoba, (unknown), John C. Hunter, Robert A. Hodgson	9
6	Multilevel Measurement of Acetabular Version Using 3-D CT-generated Models: Implications for Hip Preservation Surgery 2010 ·Clinical Orthopaedics and Related Research ·(unknown), John C. Hunter, (unknown), Amir A. Jamali	46
7	Answering the Burning Question of How Transient Receptor Potential Vanilloid-1 Channel Antagonists Cause Unwanted Hyperthermia 2009 ·Pharmacological Reviews ·Samir S. Ayoub, John C. Hunter, Daniel L. Simmons	7
8	The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates 2008 ·Psychopharmacology ·Geoffrey B. Varty, Robert A. Hodgson, Annamarie J. Pond, (unknown), Eric M. Parker, John C. Hunter	40
9	Linear and angular measurements of computer-generated models: Are they accurate, valid, and reliable? 2007 ·Computer Aided Surgery ·Amir A. Jamali, (unknown), (unknown), Christopher J. Salgado, John C. Hunter, E. Bradley Strong	28
10	Small interfering RNA-mediated selective knockdown of NaV1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats 2007 ·Neuroscience ·(unknown), (unknown), Harald Engler, Xiaoping Zhou, Lilly Mark, James H. Crona, Rebecca Terry, John C. Hunter, Tony Priestley	101
11	Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats 2007 ·European Journal of Pharmacology ·Richard W. Chapman, (unknown), Howard Jones, (unknown), Chander Celly, D. B. Prelusky, Pauline C. Ting, John C. Hunter, (unknown), Jonathan E. Phillips	40
12	[14] Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Josephine Lai, John C. Hunter, Michael H. Ossipov, Frank Porreca	26
13	Cervical Spine Tomography with an Angiographic C-arm 1999 ·Radiology ·(unknown), Anthony Wilson, Steve G. Langer, Frederick A. Mann, John C. Hunter	2
14	The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization 1997 ·Pain ·(unknown), (unknown), (unknown), John C. Hunter	103
15	Usefulness of turbo spin-echo MR imaging in the evaluation of meniscal tears: comparison with a conventional spin-echo sequence. 1996 ·American Journal of Roentgenology ·Eva M. Escobedo, John C. Hunter, (unknown), AJ Wilson, Scott Harrison, David J. Fisher	79
16	C-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression 1995 ·Neuroscience ·John C. Hunter, (unknown), C. Durieux, (unknown), Judith A. Poat, Joel W. Hughes	91
17	Differential modulation of κ and μ opioid antinociception by the glycine/NMDA receptor agonist D‐serine 1994 ·British Journal of Pharmacology ·John C. Hunter, Paldeep S. Atwal, G.N. Woodruff, L. Singh	13
18	Anaesthesia for Opthalmic Surgery 1992 ·Oxford University Press eBooks ·(unknown), (unknown), John C. Hunter, (unknown), James H. Kelly	1
19	Pd 117302 attenuates glutamate neurotoxicity in vitro 1990 ·The Society for Neuroscience Abstracts ·Mark A. DeCoster, John C. Hunter, (unknown), Frank C. Tortella	3
20	PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats 1990 ·Life Sciences ·Frank C. Tortella, Lydia Robles, (unknown), John C. Hunter, John Hughes	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact